Publication:
HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE

Simple item page
dc.contributor.authorSonneveld, Milan J.
dc.contributor.authorRijckborst, Vincent
dc.contributor.authorSenturk, HAKAN
dc.contributor.authorŞENTÜRK, HAKAN
dc.contributor.authorAKARCA, ULUS SALİH
dc.contributor.authorSimon, Krzysztof
dc.contributor.authorGerken, Guido
dc.contributor.authorBoucher, Charles A.
dc.contributor.authorHansen, Bettina E.
dc.contributor.authorJanssen, Harry L.
dc.date.accessioned2021-01-19T21:00:02Z
dc.date.available2021-01-19T21:00:02Z
dc.date.issued2010-10-01T00:00:00Z
dc.identifier.urihttp://hdl.handle.net/20.500.12645/28022
dc.identifier.wosWOS:000288775600446
dc.subjectSonneveld M. J. , Rijckborst V., Senturk H., Zeuzem S., AKARCA U. S. , Simon K., Gerken G., Boucher C. A. , Hansen B. E. , Janssen H. L. , -HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE-, 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2010, cilt.52
dc.titleHBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE
dc.typeConference Paper
dspace.entity.typePublication
dspace.relatedentity.typePerson
local.avesis.id954c68ff-44c3-4e2e-b4cf-db0bec1b67f0
local.indexed.atWOS
local.publication.isinternational1
person.identifier.orcid0000-0002-2440-4478
relation.isAuthorOfPublication278fcf63-3b92-4368-bff6-f140ebd9aeb3
relation.isAuthorOfPublication.latestForDiscovery278fcf63-3b92-4368-bff6-f140ebd9aeb3
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Yayınlar - Eserler